Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Says Pilot On Standard Electronic Labeling For Devices “Didn’t Work”

This article was originally published in The Gray Sheet

Executive Summary

CDRH’s five-company pilot study on electronic transmission of standard device labeling information spotlighted some serious challenges with the practice, according to a policy advisor at the center.

You may also be interested in...



Home-Use E-Labeling Pilot Round 2: CDRH Seeks Volunteers

FDA’s device center issued a request to participate for a pilot asking companies to electronically submit labeling for home-use devices to help develop a label database. This is the agency’s second go at such a pilot but the submissions process appears to be simplified this time around.

FDA Outlines Next Steps For Online Repository And Standard Elements For Device Labeling

Industry representatives, health care providers, patients and caregivers gathered April 29-30 to discuss CDRH labeling activities and the agency’s ideas for the future.

FDA Proposes Rule On Symbols In Device Labeling

By allowing for the inclusion of stand-alone standardized symbols on medical device labeling, FDA seeks to harmonize U.S. regulatory requirements with those of the European Commission.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031865

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel